Literature DB >> 6606797

DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose.

L J Baraff, C L Cody, J D Cherry.   

Abstract

Local and less serious systemic reactions are frequent following immunization with diphtheria-tetanus-pertussis (DTP) vaccine. The effects of injection site, manufacturer, previous reactions, and dosage reduction upon subsequent reactions to DTP immunization were investigated. Local reactions, notably pain and swelling, were less common when the immunization was given in the buttocks than in the thigh. No injection site was consistently associated with lower systemic reaction rates. There was no significant difference in the rate of more serious reactions by vaccine manufacturer. Differences in rates of less serious reactions by manufacturer were observed but seemed to be related to vaccine lot differences rather than the specific vaccines. In a subset of 772 children, in whom data regarding sequential reactions were available, it was noted that all three reactions investigated--local redness, temperature greater than or equal to 39 degrees C, and persistent crying longer than one-half hour--were two to three times more frequent on a subsequent immunization when present on a prior vaccination than if not present on a prior vaccination than if not present previously. One hundred children received a half dose of DTP vaccine because of a less serious reaction associated with prior immunization. In all instances, they had significantly less serious local reactions as well as notable differences in temperature, drowsiness, and persistent crying.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6606797

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

1.  Pertussis: the disease and the vaccine.

Authors:  R Gold
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

2.  Site for immunising infants.

Authors:  M K Thompson
Journal:  BMJ       Date:  1992-05-02

3.  Symptoms after accelerated immunisation.

Authors:  D Burgner; P Chetcuti
Journal:  BMJ       Date:  1992-07-18

Review 4.  When should vaccination be contraindicated in children?

Authors:  Laura Lane; Arlene Reynolds; Mary Ramsay
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Symptoms after accelerated immunisation.

Authors:  M E Ramsay; M Rao; N T Begg
Journal:  BMJ       Date:  1992-06-13

6.  Adverse events temporally associated with immunizing agents: 1987 report.

Authors: 
Journal:  CMAJ       Date:  1989-11-01       Impact factor: 8.262

7.  Prophylactic use of acetaminophen in children vaccinated with diphtheria-tetanus-pertussis.

Authors:  S Songül Yalçin; Ayça Gümüş; Kadriye Yurdakök
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

Review 8.  The past, present, and future of pertussis. The role of adults in epidemiology and future control.

Authors:  J D Cherry; L J Baraff; E Hewlett
Journal:  West J Med       Date:  1989-03

Review 9.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

10.  Reactogenicity of fluid compared with adsorbed diphtheria-pertussis-tetanus vaccine.

Authors:  R G Mathias
Journal:  Can Med Assoc J       Date:  1984-06-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.